Photo: Chris Asadian
As the boundaries between academic medicine and the pharmaceutical companies dissolve, research, education, and clinical practice suffer.
Selling Diseases
The Challenge of Public Expectations
The Case of H1N1
No Such Thing As a Free Sample
A letter challenging Angells claims.
Unhealthy Opposition: The value of academic-industry relationships
A Partnership Worth Promoting
Dont Forget Nurses
Restore Medicine to the Commons
A Question of Commitments
Photo: flickr.com/emagic
